Latest news
Researchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections
Researchers have identified a bacterial enzyme that may be the reason some people get heart complications with pneumonia, while others do not. Since enzymes create chemical reactions to help bacteria survive, grow, and sometimes attack tissues, zmpB could become a target for future therapies.
Volcanic eruptions set off a chain of events that brought the Black Death to Europe
Researchers have used a combination of climate data and documentary evidence to paint the most complete picture to date of the ‘perfect storm’ that led to the deaths of tens of millions of people, as well as profound demographic, economic, political, cultural and religious change.
To treat long COVID, we must learn from historical chronic illnesses, medical researchers say
Scientists and doctors have highlighted the importance of studying long COVID in the context of other post-acute infection syndromes or chronic illnesses. By analyzing historical accounts of other epidemics, researchers can gain important perspective on the effects of these chronic illnesses.
Microbiome of an entire country is mapped for the first time
An international research team has systematically mapped the microbiome of an entire country for the first time. More than 10,000 environmental samples from across Denmark were analyzed, resulting in an atlas of environmental microbiomes with unprecedented spatial resolution and functional depth.
New tools saved a million lives from malaria last year but progress under threat as drug resistance rises
Wider use of new tools against malaria, including dual-ingredient nets and WHO-recommended vaccines helped to prevent an estimated 170 million cases and 1 million deaths in 2024, according to WHO’s annual World Malaria Report.
Do oral bacteria from tooth infections worsen diabetes risk?
A new study demonstrates that Porphyromonas gingivalis and its lipopolysaccharide are potent drivers of both periapical bone destruction and systemic metabolic dysfunction, acting through an IL-17–dependent inflammatory pathway.
Researchers identify bacterial enzyme that can cause fatal heart conditions with pneumonia infections
Researchers have identified a bacterial enzyme that may be the reason some people get heart complications with pneumonia, while others do not. Since enzymes create chemical reactions to help bacteria survive, grow, and sometimes attack tissues, zmpB could become a target for future therapies.
Volcanic eruptions set off a chain of events that brought the Black Death to Europe
Researchers have used a combination of climate data and documentary evidence to paint the most complete picture to date of the ‘perfect storm’ that led to the deaths of tens of millions of people, as well as profound demographic, economic, political, cultural and religious change.
To treat long COVID, we must learn from historical chronic illnesses, medical researchers say
Scientists and doctors have highlighted the importance of studying long COVID in the context of other post-acute infection syndromes or chronic illnesses. By analyzing historical accounts of other epidemics, researchers can gain important perspective on the effects of these chronic illnesses.
Apriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
Typhoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.®
CARBIOS and Wankai New Materials to build PET biorecycling plant in China
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
Researchers use ‘brain-on-a-chip’ to revolutionize fight against deadly encephalitis viruses
A transparent chip no larger than a stick of gum is helping scientists transform the way researchers study the human brain and develop treatments for some of the world’s deadliest viruses.
Single-cell movies reveal how host physiology sets phage success - and how to time therapies
A new study outlines how an innovative tool can be used to help uncover the reasons why phages succeed or fail when used to target bacterial infections.
New test distinguishes vaccine-induced false positives from active HIV infection
A new device correctly identified those with active HIV-1 infection 95% of the time and those without active infection but with vaccine-induced molecules that could trigger a false positive, 98% of the time.
Cedars-Sinai and Exobiosphere partner to launch biomedical research aboard the Haven-1 Space Station
Cedars-Sinai is partnering with Exobiosphere, a company that has developed scientific hardware to automate biomedical research in space and on Earth, and will send experiments to Haven-1, set to become the world’s first commercial space station.
Professor named EMBO Young Investigator for work on the infant microbiome
Prof. Moran Yassour has been selected as one of the 2025 EMBO Young Investigators. She receives this prestigious recognition for her innovative research on the developing infant microbiome and its impact on pediatric health.
Horizon Awards 2025: Max Fisher named as individual winner of Dorothy Jones Award
Max Fisher, a leading Disability & LGBTQIA+ Advocate, and Senior Research Associate at ViaNautis Bio, has been named as individual winner of the Dorothy Jones Diversity & Inclusion Achievement Award 2025.